stock_PFE r_up	cheese:1 exports:1 said:1 zone:1 company:1 50:1 dairy:1 seeks:1 half:1 beyond:1 boost:1 buying:1 euro:1
stock_PFE r_up	crash:1 help:1 avoid:1 landing:1 can:1 portfolio:1 2014:1 you:1 writes:1 recovery:1
stock_PFE r_up	them:1 after:1 they:1 released:1 drugs:1 many:1 medical:1 months:1 use:1 major:1 confused:1 not:1 other:1 guidelines:1 whether:1 groups:1 statins:1 need:1 new:1 you:1 should:1
stock_PFE r_up	named:1 founder:1 certain:1 energy:1 manager:1 businesses:1 have:1 portfolio:1 decisions:1 market:1 staffers:1 said:1 pharma:1 insider:1 six:1 42:1 wo:1 recommended:1 winners:1 influences:1 recognize:1 teaching:1 percentage:1 2013:1 's:1 finance:1 beat:1 first-time:1 chiefs:1 deposition:1 important:1 preference:1 post:1 former:1 hired:1 n't:2 trial:1 points:1 place:1 workplace:1 trading:1
stock_PFE r_down	show:1 manager:1 trading:1 sought:1 portfolio:1 profitable:1 trial:1 perform:1 ideas:1 under:1 upbeat:1 extreme:1 meeting:1 his:1 deliver:1 employers:1 pressure:1 despite:1 insider-trading:1 former:1 diabetes:1 drug:1 remains:1
stock_PFE r_up	all:2 just:1 planning:1 red-hot:1 writes:1 had:2 auditors:2 controls:3 environment:1 citing:1 going:1 equity:1 2014:1 2013:1 far:2 --:1 warned:1 notes:1 companies:2 she:1 found:2 mergers:1 shed:1 because:1 financial:1 tougher:1 year:2 discussions:1 close:1 audits:4 makers:1 encouraged:1 said:1 lukewarm:1 section:1 everything:1 generics:1 capital:1 business:1 reported:1 active:1 last:1 getting:1 turn:1 executives:2 raised:1 year-end:1 number:1 management:1 raise:1 people:1 three:1 their:3 interest:1 branded:1 markets:1 today:1 more:2 ``:3 but:1 controller:1 external:2 focusing:1 than:2 buying:1 '':3 14:1 reviews:1 matter:1 're:1 budgets:1 were:1 high:3 say:2 warning:1 have:1 documents:2 no:1 internal:3 details:2 units:1 really:1 's:7 after:1 alert:2 levels:2 acquisitions:1 assets:1 pension:1 time:1 came:1 usual:2
stock_PFE r_up	increasingly:1 over:1 executive:1 turned:1 direct:1 '':2 manager:4 trading:2 portfolio:3 any:1 witness:1 even:1 said:2 doctor:2 government:1 officers:1 their:1 clinical:2 might:1 ``:2 's:1 confidential:3 though:1 company:1 knew:2 problems:1 boss:1 hear:1 key:1 not:1 insider-trading:1 line:1 results:3 former:3 he:5 realized:2 getting:1 drug:2 trial:5 chief:1 insider:2 eager:1
stock_PFE r_up	20:1 return:1 offer:1 dividends:1 including:1 should:1 5:1 4:1 which:1 2014:1 yields:1 than:1 more:1
stock_PFE r_down	firm:1 bolster:1 training:1 compliance:1 sessions:1 could:1 annual:1 two:1 against:1 years:1 fund:1 manager:1 said:1 portfolio:1 officer:1 case:1 testimony:1 insider-trading:1 hedge:1 former:1 row:1
stock_PFE r_up	help:1 over:1 expects:1 trade:2 session:2 daunting:1 its:5 increase:1 number:1 $:3 merger:1 treatment:1 8:1 weeks:1 noncash:1 bid:1 primary:1 reversal:1 2:1 month:1 secondary:1 companies:2 fixed:1 related:1 3.4:1 actively:2 's:2 gradually:1 said:4 capacity:1 shares:2 current:1 favor:1 3:1 unable:1 safety:1 approach:1 quitting:1 measuring:1 million:1 met:1 scrapped:1 abruptly:1 quarter:1 study:3 drug:1 carrier:1 products:1 smokers:3 maker:1 first:1 fourth-quarter:1 followed:1 within:1 period:1 reducing:2 quit:3 clinical:1 12-week:1 expected:2 ``:1 efficacy:1 gain:1 smoking:2 valuation:1 pact:1 12:1 up:1 patients:1 can:1 were:2 endpoints:1 treated:1 tax:1 '':1 earnings:1 which:1 test:1 144:1 used:1 edged:1 date:1 why:1 soared:1 billion:1 cigarettes:1 smoked:1
stock_PFE r_up	information:1 's:1 confidential:1 lied:1 government:1 federal:1 top:1 explained:1 former:1 manager:1 portfolio:1 passing:1 investigators:1 why:1 witness:1 he:1
stock_PFE r_down	heart:1 2014:1 cancer:1 people:1 simple:1 back:2 agent:1 dose:1 chronic:2 fortunes:1 hepatitis:1 such:1 's:2 80:1 strategy:1 its:1 given:1 said:1 3:1 same:1 while:1 investigational:1 safety:1 treatment:1 test:1 5:1 fairly:1 treat:1 meant:1 then:1 high-yielding:1 pain:2 12-week:1 efficacy:2 could:1 use:1 regimen:1 primary:1 met:1 capsule:1 low:1 others:1 during:1 stocks:1 continued:1 day:1 payout:1 10:1 lower:1 endpoint:1 failure:1 these:1 boost:2 study:2 companies:1 drug:3 options:1 twice:1 patients:1 period:1 can:1 were:2 placebo:1 maker:1 six-week:1
stock_PFE r_down	fourth-quarter:1 adjusted:1 cancer:1 revenue:1 portfolio:1 said:1 away:1 spread:1 health:1 earnings:1 new:1 until:1 therapies:1 hurdles:1 pushing:1 recently:1 emergency:1 benefiting:1 company:1 rise:1 but:1 reported:1 antibiotics:1 dire:1 regulatory:1 aiming:1 expand:1 search:1 improved:1 many:1 economics:1 companies:1 drug:1 were:1 better-than-expected:1
stock_PFE r_down	operations:1 fourth-quarter:1 expanded:1 stores:1 cancer:2 groundwork:1 laying:1 mobile-payments:1 trade:2 rate:1 session:2 through:1 file:1 2.2:1 decisions:1 its:8 utility:1 objective:2 said:2 $:1 service:1 trial:1 trials:1 expectations:1 shares:3 improvement:1 cell:1 previously:1 growth:1 earnings:1 premarket:1 expected:2 millions:1 advanced:1 survival:2 treatment:1 versus:1 customers:1 pushing:1 's:2 users:1 business:1 beat:1 leveraging:1 after:1 overall:1 hundreds:1 cards:1 most:1 base:1 therapy:2 goals:1 significant:1 offset:1 soared:1 compared:1 placebo:1 benefits:1 did:3 treated:1 study:1 losses:1 companies:2 up:1 drug:1 n't:3 credit:1 patients:1 actively:2 second:1 growing:1 lung:1 first:1 studies:1 called:1 two:1 meet:3
stock_PFE r_up	polled:1 expects:1 trade:1 manager:1 session:1 exclusivity:1 forecast:1 year-earlier:1 skid:1 previous:1 whose:1 $:7 former:1 company:2 voted:1 under:1 2014:1 weeks:1 gains:3 rebound:1 rise:1 watch:1 results:2 early:1 worst:1 know:1 report:2 breast-cancer:1 hedge:1 continued:1 day:1 59:2 name:1 lost:1 did:1 hunt:1 companies:3 maker:1 popular:1 found:1 2.20:1 related:1 heavy:1 weighs:1 bolstering:1 elderly:1 challenges:1 see:2 year:2 targets:1 best:1 said:3 sentiment:1 profit:1 review:1 schedule:1 shares:1 its:4 increase:1 activist:1 market:1 new:1 earlier:1 led:1 business:1 defenses:1 sold:1 durable:1 pressure:1 step:1 active:1 vaccine:1 faced:1 comparison:1 goods:1 ahead:1 trader:1 losses:2 drug:2 investment:1 trial:1 massive:1 dents:1 bruised:1 experimental:1 fourth-quarter:1 major:1 tough:1 revenue:2 period:1 two:2 feet:1 included:1 carry:1 risk:1 pharmaceutical:1 use:1 top:1 three:1 per-share:2 anyone:1 their:4 clinical:1 expected:2 markets:1 firm:2 nutrition:1 mining:1 sessions:1 drugs:2 funds:1 brand:1 gain:1 than:1 rival:1 up:2 value:1 n't:1 pneumonia:1 while:1 following:1 company’s:1 sees:1 have:1 investors:1 pare:2 disappointing:2 want:1 face:1 painkillers:1 end:1 began:1 4.8:1 indexes:1 also:1 lifts:1 earnings:3 which:1 stepped:1 breaks:1 stock:2 's:2 may:1 after:1 fell:1 shareholder:1 cardiac:1 5-day:1 stocks:4 data:1 billion:4 lower:1 futures:2 roughly:1 skids:1 divestiture:1 tech:2 rallies:1 position:1 2008:1 latest:1
stock_PFE r_down	control:1 limited:1 own:1 surprises:1 show:1 over:1 trade:1 rate:1 trading:1 want:1 further:1 decisions:1 pharmaceutical:1 jurors:1 rose:1 began:1 breaking:1 had:1 two:1 including:1 increase:1 advisories:1 earnings:1 announced:1 told:1 firm:1 roundup:1 his:1 's:3 tried:1 five-session:1 big:1 streak:1 know:1 saying:1 losing:1 trader:1 quarters:1 bank:1 he:1 gained:1 central:1 did:1 employees:1 futures:1 companies:2 reports:1 n't:1 future:1 massive:1 after-hours:1 position:1 2008:1 latest:1 corporate:1 top:1 anyone:1
stock_PFE r_up	information:1 he:1 jurors:1 allegedly:1 received:1 actually:1 witness:1 before:1 told:1 confidential:1 public:1 behalf:1 expert:1
stock_PFE r_up	distributors:1 reinvigorate:1 agreed:1 global:1 results:1 effects:1 trade:2 manager:2 session:2 through:1 portfolio:2 its:5 $:1 had:2 program:1 treatment:2 premarket:1 has:1 diseases:1 combination:2 government:1 big:3 survival:1 early:1 breast:3 during:1 him:2 advanced:3 like:1 medicines:1 companies:4 transform:1 officer:1 fitness:1 including:1 quarter:1 right:1 significantly:1 told:1 actively:2 picked:1 's:5 2.5:1 provided:1 said:3 network:1 federal:1 shares:2 new:1 newly:1 discovery:1 shakes:1 weak:1 standard:1 met:1 weight-loss:1 operating:1 alone:1 estimate:1 care:1 prosecutors:2 study:2 trades:2 according:1 drug:2 trial:2 range:1 products:1 diagnosed:1 maker:1 first:1 fourth-quarter:1 raised:1 cancer:3 primary:1 two:1 66:1 pharmaceutical:1 unusual:1 jurors:1 comparing:1 illegal:2 locally:1 system:2 their:1 clinical:1 statement:1 expected:2 ``:2 buy:1 formed:1 but:1 improved:1 former:1 women:2 pact:1 wide:1 endpoint:1 showed:1 up:2 closing:1 certain:1 '':2 warning:1 have:1 allowed:2 sells:1 suggests:1 make:2 potential:1 outlook:1 stock:1 independent:1 edged:1 boosted:1 treatments:1 buyback:1 stocks:1 types:1 diabetes:1 2:1 off:1 medical:1 chief:1 left:1
stock_PFE r_up	schemes:1 weaker-than-expected:1 gold:1 producer:1 one:1 see:1 accused:1 losses:1 portfolio:1 market:1 manufacturing:1 adds:1 fate:1 began:1 selloff:1 expectations:1 shares:1 rally:1 successful:1 earnings:1 above:1 several:1 ever:1 announced:1 stock:1 jury:1 extend:1 slumping:1 wake:1 after:2 most:1 worst:1 gain:1 insider-trading:1 stocks:2 data:1 former:1 mood:1 reading:1 prosecutors:1 downbeat:1 months:1 manager:1 drug:1 trial:1 while:1 2013:1 lucrative:1 higher:1 called:1
stock_PFE r_down	fourth-quarter:1 weaker:1 cancer:2 sales:1 related:1 expenses:1 's:2 its:2 confirmed:1 said:1 system:1 immune:1 three:1 also:1 investigational:1 other:1 agreements:1 new:1 entered:1 has:1 target:1 therapies:1 earnings:1 cost-cutting:1 collaborate:1 hit:1 immunotherapy:1 combination:1 separate:1 drugs:1 evaluate:1 collaboration:1 unleash:1 body:1 fell:1 treatment:1 class:1 drugmaker:1 14:2 --:1 cells:1 part:1 promising:1 efforts:1 drugmakers:1 studies:1 experimental:1
stock_PFE r_up	says:1 cancer:1 immunotherapy:1 manager:1 defense:1 its:1 witness:1 jurors:1 three:1 day:1 their:1 investigational:1 agreements:1 new:1 entered:1 treatment:1 's:1 drugs:1 evaluate:1 collaboration:1 promising:1 class:1 part:1 insider-trading:1 former:1 deliberations:1 second:1 drug:1 asked:1 trial:1 testimony:1 maker:1 experimental:1
stock_PFE r_up	over:1 household-name:1 pain:1 like:1 fate:1 drugs:1 could:1 pose:1 question:1 direct:1 billions:1 soon:1 cardiac:1 ones:1 which:1 greater:1 dollars:1 risk:1 panel:1
stock_PFE r_up	fourth-quarter:2 livestock:2 revenue:2 sales:2 businesses:2 carry:2 swung:2 its:2 out:2 profit:2 than:2 drugs:2 laid:2 cardiovascular:2 higher:2 comparable:2 pain:2 increased:2 may:2 why:2 posted:2 both:2 lower:2 animals:2 --:1 drug:2 risks:2 maker:2
stock_PFE r_down	advisory:1 evidence:1 painkiller:1 years:1 say:1 committee:1 dividend:1 pain:1 beyond:1 pharmaceutical:1 little:1 there:1 had:1 enough:1 other:1 health:1 voted:1 recommend:1 has:1 's:2 drugs:1 company:1 largest:1 world:1 safer:1 now:1 than:1 pipeline:1 n't:1 promising:1 heart:1 comes:1
stock_PFE r_up	court:2 market:2 power:2 antitrust:1 --:1 local:2 alleging:2 sale:2 competition:1 its:3 regulator:1 medicine:2 proceedings:2 against:2 misused:2 popular:2 watchdog:1 has:1 's:2 arm:2 launched:2
stock_PFE r_down	's:1 greater:1 proposed:1 antitrust:1 --:1 trillion:1 $:1 competition:2 economy:1 ensure:1 submitted:1 1.2:1 authorities:1 new:1 law:1 powers:1 gives:1
stock_PFE r_up	proposed:1 competition:2 1.2:1 partner:1 decade:1 recently:1 $:1 trillion:1 investigations:1 new:1 has:1 economy:1 firm:1 gives:1 head:1 's:1 greater:1 government:1 after:1 most:1 authorities:1 law:2 than:1 he:1 antitrust:1 joined:1 submitted:1 ensure:1 more:1 powers:1
stock_PFE r_down	shortages:1 short:2 dogged:1 prompted:2 supply:2 recall:2 lapse:2 resume:2 drug:3 one:1 past:2 shipping:2 have:1 year:2 years:1 many:1 industry:1 after:2 recent:1
stock_PFE r_up	prevent:1 serving:1 dean:1 adults:2 illnesses:1 caused:1 years:1 showed:1 's:1 aged:1 its:1 causes:1 said:2 trial:2 retiring:1 bacteria:2 member:1 clinical:1 treatment:1 which:2 largest:1 occur:1 several:1 more:1 meant:1 kinds:1 diseases:1 efficacy:1 prevented:1 after:1 infection:1 tested:1 enters:1 than:1 vaccine:4 13:2 effectiveness:1 65:1 58:1 longest-serving:1 older:2 study:1 against:1 s.:1 pneumonia:3 patients:1 makes:1 history:1
stock_PFE r_down	index:1 beaten:1 dividend-paying:1 low-risk:1 names:1 7:1 has:1
stock_PFE r_up	available:1 both:1 would:1 drugs:1 scrap:1 other:1 limit:1 plan:1 parties:1 through:1 seniors:1 asked:1 types:1 antidepressants:1
stock_PFE r_down	verdict:1 trial:1 guilty:1 new:1 asked:1 insider:1 manager:1 trading:1 have:1 found:1 portfolio:1 overturned:1 former:1
stock_PFE r_down	year-end:1 global:1 through:1 determine:1 statin:1 any:1 denies:1 pharmaceutical:1 over-the-counter:1 due:1 research:1 version:2 crisis:1 largest:1 clinical:1 has:1 markets:1 completed:1 sent:1 sell:1 's:1 company:1 but:1 admits:1 regulatory:1 approval:1 data:1 chill:1 whether:1 aims:1 trial:1 escalating:1 applies:1 become:1 first:1
stock_PFE r_up	medication:1 they:1 related:1 three:1 report:1 another:1 watched:1 said:1 group:1 asks:1 lots:1 negative:1 adverse:2 citing:1 potential:1 contained:1 conduct:1 has:1 cause:1 events:2 product:1 drugs:1 aware:1 capsule:1 closely:1 regulatory:1 one:1 recall:1 cognitive:1 assessment:1 pharmacist:1 drug:1 antidepressant:1 bottle:1 cholesterol:1 become:1 anti-cholesterol:1 filing:1 experimental:1
stock_PFE r_up	information:1 instant:1 get:1 communication:1 age:1 proven:1 patients:1 doctors:1 's:1 works:1
stock_PFE r_down	prevent:1 adults:1 reduce:1 primary:1 trade:1 episodes:3 session:1 through:1 65:1 kinds:1 its:1 said:2 trial:1 46:1 there:1 able:1 fewer:1 shares:1 contact:1 spread:1 those:1 expected:1 several:1 versus:1 's:2 ability:1 normal:1 showing:1 were:1 met:1 nearly:1 years:1 vaccine:2 secondary:1 received:1 13:2 placebo:1 older:1 --:2 study:1 companies:1 drug:1 pneumonia:6 patients:1 actively:1 social:1 landmark:1 endpoints:1 treated:1 maker:1 first:3
stock_PFE r_down	fourth-quarter:1 weaker:1 version:1 revenue:1 blockbuster:1 sales:1 related:1 trade:1 '':1 rate:1 session:1 drug:1 have:1 year:1 2.2:1 edged:1 margins:1 energy-efficiency:1 offered:1 its:3 plans:1 generic:1 favorable:1 said:4 court:2 raise:1 would:2 federal:2 painkiller:1 shares:1 increase:1 start:1 exclusivity:1 offers:1 growth:1 earnings:1 which:1 expected:1 nine-year:1 company:1 ``:1 selling:1 's:5 video-streaming:1 months:1 price:1 free:1 99:1 membership:1 fell:1 additional:1 offset:1 such:1 69:1 79:1 $:3 prime:1 has:1 renewable-energy:1 service:1 monopoly:1 18:1 premarket:1 companies:1 up:1 shipping:2 expedited:1 patent:2 perks:1 actively:1 ruling:1 reissue:1 history:1 called:1 first:1
stock_PFE r_up	head:1 giant:1 join:1 business:1 sales:1 medical:1 departure:1 leaving:1 food:1 market:1 sputter:1 's:3 comes:1 charity:1
stock_PFE r_up	unexpected:1 cancer:1 results:1 disappointing:1 currency:1 set:1 entering:1 year:1 quieter:1 research:1 new:1 development:1 's:2 company:1 served:1 phase:1 vaccine:1 volatility:1 could:1 drug:1 n't:1 trial:1 were:1 highlight:1 latest:1
stock_PFE r_up	all:2 force:1 legislation:1 into:1 within:1 estimates:1 results:4 month:2 vote:1 paper:1 including:1 go:1 year:1 unfavorable:2 if:2 different:1 would:2 no:2 trials:3 able:2 next:2 current:1 3:1 clinical:2 passed:2 expected:2 new:2 2016:1 full:1 half:1 report:1 law:3 come:1 longer:2 countries:1 ending:1 studies:1 require:1 companies:2 according:1 withhold:2 looked:1 trial:2 plus:1 published:1 2009:1 changes:2 researchers:2
stock_PFE r_down	sector:1 investors:1 straight:1 selloff:1 while:1 negative:1 also:1 second:1 session:1 focused:1 biotechnology:1 out:1 data:1 declined:1 economic:1
stock_PFE r_up	fourth-quarter:1 chain:1 revenue:1 certain:1 among:1 sales:1 trade:2 disappointing:1 62:1 session:2 decrease:1 thanks:1 year:1 partly:1 margins:1 offered:1 its:4 decline:1 cancer:2 said:3 $:1 superior:1 jumped:1 brand:1 stocks:1 current:1 bottom-line:1 earnings:2 7:1 which:1 expected:2 chemotherapy:1 type:1 across:1 treatment:1 's:2 premarket:1 business:1 views:1 dropped:1 big:1 company:1 overall:1 tied:1 forecasts:1 reported:1 strength:1 offset:1 15:1 expenses:1 finding:1 second-quarter:1 advanced:1 recent:1 fiscal:2 grew:1 improved:1 restaurant:1 underpriced:1 study:1 cell:1 companies:2 pharma:1 drug:1 costs:1 below:1 actively:2 acquisition:1 retailers:1 banks:1 lung:1 quarter:1 fell:1 shoe:1
stock_PFE r_up	illustrates:1 money:1 over:1 trade:2 session:2 including:1 years:1 its:3 24:2 $:1 dilutive:1 heavily:1 29:1 should:1 record-breaking:1 those:2 premarket:2 2014:1 2013:1 blistering:1 survival:1 early:1 increases:1 additional:1 half:1 month:1 regarding:1 did:1 tumors:1 early-stage:1 companies:3 50:1 continue:1 each:1 injectable:1 heavy:1 propel:1 trend:1 some:1 back:1 born:1 actively:2 year:2 fail:1 close:1 matching:1 said:2 shares:3 children:3 safety:1 between:1 receiving:1 seeks:1 bought:1 terms:1 dividends:1 sold:1 million:1 discount:1 debt:1 generate:1 proceed:1 last:1 catch-up:1 study:4 months:3 drug:3 trial:2 planned:1 experimental:1 cancer:2 height:1 61:1 lung:1 improvement:1 market:1 pharmaceutical:1 raise:1 would:1 prove:1 data:2 achieve:1 two:1 least:1 next:1 expected:4 final:1 more:1 form:1 company:1 benefits:1 rare:1 than:1 buying:1 disappointing:1 showed:2 16:1 n't:1 pace:1 patients:1 growth:1 sharp:1 reshaping:1 biotech:1 30:1 hoping:1 cents:1 ages:1 purposes:1 helped:1 dropped:2 unveiled:1 genomic:1 rally:1 end:1 efficacy:1 which:1 sufficient:1 stock:3 development:1 analysts:1 's:8 intended:1 price:1 after:1 paid:1 shrank:1 significant:2 included:1 prostate:1 payment:1 age:1 later:1 sale:2 analysis:1
stock_PFE r_down	consulting:1 benefited:1 significantly:1 slipped:1 revenue:1 expectations:1 raised:1 trade:1 dosing:1 full-year:1 session:1 forecast:1 its:4 cardiovascular:1 litigation:1 said:3 $:2 would:1 pay:1 top:1 outsourcing:1 shares:2 improvement:1 2:1 earnings:2 premarket:1 expected:1 9.5:1 several:1 across:1 treatment:1 firm:1 billion:1 all:1 settle:1 's:2 risk:1 business:1 company:1 levels:1 second-quarter:1 missed:1 fiscal:1 high:1 grew:1 study:1 companies:1 events:1 patients:1 actively:1 2b:1 cholesterol:1 anti-cholesterol:1 slightly:1 reduced:1 experimental:1
stock_PFE r_down	well:1 expected:1 insulin:1 go:1 regulatory:1 meeting:1
stock_PFE r_up	seeing:1 0.4:1 led:1 concentration:1 technology:1 said:1 $:1 spending:1 top:1 trillion:1 also:1 firms:1 2013:1 's:2 power:1 very:1 12:1 non-financial:1 grew:1 piles:1 companies:1 cash:1
stock_PFE r_down	may:1 trials:1 require:1 drug:1 approving:1 prior:1 cholesterol:1 outcomes:1
stock_PFE r_down	sector:1 just:1 over:1 results:1 you’re:1 writes:1 need:1 portfolio:1 your:1 if:1 use:1 cancer:1 make:1 debate:1 rewarding:1 got:1 you:2 500:1 stock:1 them:1 funds:2 exactly:1 cheaper:1 early:1 understand:1 breast:1 new:1 buying:1 cheapest:1 amid:1 study:1 drug:2 maker:1 can:2 promising:1 whole:1 investments:1
stock_PFE r_down	heavy:1 losses:1 deal:1 soars:1 over:1 seesaw:1 broader:1 market:2 accepted:1 began:1 since:1 selloff:1 which:1 has:1 2011:1 momentum:1 stock:1 week:1 selling:1 extend:1 bid:1 continues:1 falls:1 worst:1 surges:1 sharply:1 fall:1 buyout:1 stocks:3 after:1 loss:1 last:1 announcing:1 spill:1 3-day:1 while:1 high-growth:1 following:1
stock_PFE r_up	case:1 articles:1 giant:1 's:1 pressured:1 make:1 drug:1 competitor:1
stock_PFE r_down	deal:1 providers:1 agreed:1 health-care:1 terminate:1 strategic:1 including:1 another:1 reached:1 technology:1 its:1 pharmaceutical:1 said:3 $:1 would:1 pay:1 2:1 expand:1 fourth:1 under:1 new:1 brand:1 2013:1 product:1 's:1 company:2 million:1 agreement:1 pain:1 potential:1 relaunch:1 name:1 license:1 rights:1 drug:1 products:1 evaluating:1 termination:1 quarter:1 options:1
stock_PFE r_up	settling:1 lower:1 said:1 's:2 patent:1 after:1 able:1 due:1 across:1 currency:1 2.9:1 version:1 board:1 year:1 release:1 end:1 its:1 dispute:1
stock_PFE r_up	private:1 including:1 your:1 finance:1 rose:1 had:1 been:1 equity:1 biggest:1 's:1 approached:1 beat:1 funds:1 company:1 possible:1 early:1 takeover:1 news:1 hedge:1 rival:1 drug:1 morning:1 amid:1 banks:1 trading:1 speculation:1 maker:1
stock_PFE r_up	sector:2 help:1 just:1 global:1 focus:3 four:1 course:1 through:1 portfolio:1 its:4 24:1 adding:1 overhaul:1 $:4 should:1 concerns:1 equity:1 decades:1 worth:1 grip:1 do:1 narrows:1 return:1 finance:1 beat:1 portfolios:1 bid:2 they:2 sweeping:1 hedge:1 areas:1 companies:2 morning:1 deals:2 mega-mergers:1 25:1 activity:1 including:1 speculation:2 mergers:1 65:1 postholiday:1 deal:2 two-week:2 series:1 past:1 heavyweight:1 trading:1 animal-health:1 allay:1 makers:1 best:1 leave:1 lead:1 decision:1 shares:2 vaccines:2 between:1 announced:1 led:1 business:2 pharmaceutical:4 hours:1 takeover:2 defensive:1 news:2 rises:1 stage:1 advance:1 receive:1 quiet:1 drug:2 products:1 shakeup:1 threat:1 makes:1 think:1 reversing:1 own:1 cancer:1 suddenly:1 private:1 one:1 rising:2 least:1 another:1 your:1 broadening:1 their:1 mounting:1 been:1 pharmaceuticals:1 biggest:1 markets:2 more:3 acquisitions:2 selling:1 drugs:2 funds:1 acquire:1 demand:1 than:2 buying:1 center:1 valued:1 while:1 can:1 making:1 bet:1 unveiled:1 high:2 have:2 sells:1 empire:1 narrowly:1 5.4:2 equities:1 field:1 hot:1 potential:1 take:1 animal:1 units:2 several:1 couple:1 higher:2 gaining:1 product:1 's:6 building:1 transactions:1 after:1 treatments:1 flurry:2 climbing:1 stocks:3 billion:3 sentiment:1 amid:1 drive:1 maker:2 buoyant:1 banks:1
stock_PFE r_down	cancer-drug:1 among:1 cancer:1 series:1 vary:1 bribery:1 sudden:1 transforms:1 unveiled:1 still:1 its:1 sell:1 pharmaceutical:1 said:1 20:1 $:1 space:1 highlights:1 decision:1 there:1 makers:1 new:1 approach:1 worth:1 sent:1 more:2 week:1 's:3 around:1 business:1 transactions:1 panelists:1 big:1 consolidation:1 flurry:1 waves:1 world:1 than:1 billion:1 both:1 ahead:1 could:1 shock:1 companies:1 drug:1 growth:1 greatly:1 activity:1 industry:3
stock_PFE r_down	seven:1 painkiller:1 almost:1 over:1 sales:1 competition:1 up:1 high:1 pushed:1 need:1 perhaps:1 its:3 litigation:1 index:1 stocks:1 pharma:1 all:1 generic:3 best-selling:1 granted:1 expectations:1 shares:1 reality:1 start:1 version:2 weeks:1 has:2 higher:1 check:1 earlier:1 first-quarter:2 closes:1 drugs:1 marketing:1 company:1 after:1 dented:1 results:1 following:1 said:1 fall:1 news:1 100:1 highest:1 continued:1 posted:1 patent:1 license:1 level:1 settled:1 50:1 so-so:1 profit:1 below:1 analysts:1 leading:1 push:1 7-week:1 corporate:1
stock_PFE r_up	summer:1 shot:1 help:1 saying:1 year-to-date:1 over:2 find:1 trade:2 session:2 through:1 questions:1 using:1 talks:1 followed:1 its:3 halfway:1 outperforms:1 adding:1 giant:1 renewed:3 $:7 merger:2 much:2 had:2 enough:1 seasonally:1 compensate:1 attractive:1 main:1 ca:2 his:3 rejected:1 gains:1 big:3 bid:4 rise:1 seemingly:1 break:1 genetically:1 made:2 megamergers:1 nearly:1 not:1 world:1 continued:1 bigger:1 regarding:1 excluding:1 companies:4 yield:1 twice:1 scientist:1 including:1 higher:3 ailments:1 mergers:1 ignored:1 smaller:1 financial:1 broader:1 deal:1 woo:1 spring:1 creation:1 elderly:1 maintain:1 past:2 actively:1 trading:1 juggling:1 changed:1 declined:1 even:1 n't:4 said:1 gainers:1 missed:1 lead:1 has:5 blue-chip:1 since:1 remain:1 shares:4 research:1 behind:1 juggernaut:1 between:1 new:1 receiving:1 approach:3 law:1 discovery:1 lowest:1 specialist:1 we:1 after:1 jobs:1 jumps:1 incentives:2 shareholders:1 labs:1 takeover:3 pursuit:1 leap:1 peer:1 100:7 strong:1 pipeline:1 engage:1 rallying:1 hostile:1 ahead:1 created:1 many:1 could:3 losses:1 engineered:1 according:1 drug:4 patients:1 range:2 products:1 leading:1 top:1 designed:1 major:2 appeals:1 tone:1 cancer:1 point:2 relocation:1 into:2 intellectual:1 walk:1 weaker:1 least:1 another:1 says:1 strategy:1 open:1 market:2 pharmaceutical:2 little:1 swings:1 eye:1 puts:1 positive:1 rebuild:2 question:1 two:1 fast:1 mark:1 pharmaceuticals:2 choppy:1 treat:1 statement:1 wildly:1 expected:1 upbeat:1 markets:2 capital:1 500:1 firm:1 acquisitions:1 ``:2 buy:1 finishes:1 offering:1 offer:1 drugs:2 tax:2 company:6 surges:1 prospects:1 but:2 components:1 roller-coaster:1 surged:1 valued:1 1997:1 maker’s:1 these:1 bill:1 up:1 value:1 project:1 record:1 while:1 tag:1 making:2 property:1 3.3:1 prospect:1 heart:1 caught:1 months:2 investors:1 year:1 turned:1 stand-alone:1 '':2 middle:1 engineering:1 itself:1 have:4 seen:1 rally:1 swung:1 technology:1 bolstered:1 diseases:2 again:2 confirmed:2 blockbuster:1 end:2 patent:1 protect:1 make:2 generally:1 indexes:1 also:1 potential:1 which:1 answer:1 you:2 if:1 stock:2 200:1 sweetened:1 's:9 tried:1 price:1 lag:1 different:1 expirations:1 specialty:1 most:1 regular:1 billion-plus:1 plan:1 such:1 stocks:5 types:2 diabetes:1 billion:5 muscle:2 prefers:1 futures:2 headquarters:1 maker:1 definitely:1 agenda:1 time:1 first:1 corporate:1 talk:1
stock_PFE r_down	sector:1 spurred:1 help:1 over:2 despite:1 focus:2 years:1 manager:1 including:1 alternative:1 its:5 decade:1 relationships:1 giant:1 one:1 $:1 personal:1 nervous:1 workers:1 actually:1 only:1 disclosed:1 equity:1 has:3 2011:1 guided:1 take:1 grip:1 move:1 gains:3 means:1 far:1 could:3 bid:1 possible:1 possibly:1 boost:1 every:1 nearly:1 they:2 competing:1 hedge:1 accepted:1 day:1 bigger:1 dim:1 strengths:1 megadeals:1 --:1 turns:1 taxes:1 loses:1 large:1 continue:1 activity:1 fuel-cell:2 went:1 higher:1 suitors:1 deal:1 headwinds:1 related:1 past:1 officials:1 slumps:1 escape:1 first-quarter:1 morning:1 makers:1 best:1 resurgence:1 billions:1 said:1 gainers:1 appear:1 lead:1 federal:1 scoops:1 shares:2 your:1 state:1 're:1 between:1 get:1 advance:1 approach:1 notice:1 jobs:1 business:1 pharmaceutical:3 targeted:1 cholesterol:1 blockbusters:1 reported:1 leadership:1 if:2 pursuit:1 news:1 100:2 arena:1 received:1 prospects:2 recovering:1 nimble:1 many:1 taking:1 drug:3 aging:1 tour:1 takeover:3 place:1 trumps:1 pick:1 maker:1 executives:1 criticism:2 seeing:1 already:1 saving:1 succeeds:2 betting:1 deals:1 number:1 private:1 getting:1 rising:1 least:2 tools:1 stumble:1 market:2 decline:1 shareholders:1 legacy:1 wealth:1 would:2 political:1 two:1 been:1 few:1 biggest:2 until:1 500:1 more:1 firm:1 billion:1 buy:1 elsewhere:1 offer:3 funds:1 acquire:1 subpoenas:1 but:2 reprise:1 prices:1 ward:1 tanks:1 king:1 12:1 look:1 rival:2 official:1 economies:1 benefitting:1 pill:1 while:1 growth:2 stories:1 shift:1 employees:1 investors:2 year:1 tax:1 spent:1 player:1 have:1 statin:1 blockbuster:2 seek:1 finance:1 forced:1 moves:1 harsh:1 headquarters:1 technology:1 make:1 returning:1 beat:1 earnings:1 which:1 big:2 layoffs:1 stock:2 begin:1 's:9 huge:1 price:1 act:1 pharmacy-benefit:1 stocks:2 response:1 recent:1 acquisitions:1 lower:1 off:2 statins:1 drive:1 patent:1 allow:1 banks:1 overseas:1 corporate:1
stock_PFE r_down	battery:1 into:1 likely:1 home:1 its:2 $:1 rather:1 pay:1 slumping:1 two:1 40:1 abroad:1 better:1 other:1 split:1 policy:1 meeting:1 's:3 business:1 separate:1 plan:1 brands:1 100:1 than:1 billion:1 reaction:1 publicly:1 collective:1 performing:1 companies:1 traded:1 latest:1
